Scientists Close In on Hepatitis B Cure for 254M People

After 40 years of prevention-only treatments, European researchers are developing the first therapies that could free 254 million people from lifelong hepatitis B.

Two major clinical trials show new immune-based approaches may finally achieve what vaccines alone couldn't: a functional cure.